We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$309M
AUM Growth
+$12.7M
Cap. Flow
-$811K
Cap. Flow %
-0.26%
Top 10 Hldgs %
23.29%
Holding
133
New
3
Increased
7
Reduced
18
Closed
4

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$273K
2
PM icon
Philip Morris
PM
+$211K
3
FISV
Fiserv Inc
FISV
+$93K
4
T icon
AT&T
T
+$68.3K
5
MANT
Mantech International Corp
MANT
+$60.5K

Top Sells

Rank Stock Value
1
PRSP
Perspecta Inc. Common Stock
PRSP
+$522K
2
MRK icon
Merck
MRK
+$303K
3
SPWR
SunPower Corporation Common Stock
SPWR
+$278K
4
MUA icon
BlackRock MuniAssets Fund
MUA
+$210K
5
MO icon
Altria Group
MO
+$202K

Sector Composition

Rank Sector Weight
1 Healthcare 20.37%
2 Technology 17.64%
3 Industrials 15.32%
4 Financials 11.88%
5 Consumer Discretionary 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TT icon
101
Trane Technologies
TT
$100B
$552K 0.18%
3,000
– –
B
102
DELISTED
Barnes Group Inc.
B
$513K 0.17%
10,000
– –
MCO icon
103
Moody's
MCO
$82.8B
$507K 0.16%
1,400
– –
BWA icon
104
BorgWarner
BWA
$13.1B
$490K 0.16%
11,474
– –
TTE icon
105
TotalEnergies
TTE
$195B
$480K 0.16%
10,600
– –
SIGI icon
106
Selective Insurance
SIGI
$5.65B
$444K 0.14%
5,474
– –
LH icon
107
Labcorp
LH
$25B
$443K 0.14%
1,871
– –
WRK
108
DELISTED
WestRock Company
WRK
$442K 0.14%
8,300
– –
NWL icon
109
Newell Brands
NWL
$2.38B
$435K 0.14%
15,850
+750
+5% +$20.7K
MSI icon
110
Motorola Solutions
MSI
$72.3B
$433K 0.14%
1,995
– –
TEVA icon
111
Teva Pharmaceuticals
TEVA
$40.8B
$431K 0.14%
43,550
– –
DVN icon
112
Devon Energy
DVN
$52.1B
$409K 0.13%
14,018
– –
EMN icon
113
Eastman Chemical
EMN
$8B
$397K 0.13%
3,400
– –
RDS.A
114
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$391K 0.13%
9,672
– –
NVT icon
115
nVent Electric
NVT
$24.9B
$312K 0.1%
10,000
– –
CXT icon
116
Crane NXT
CXT
$2.99B
$296K 0.1%
9,213
– –
DEO icon
117
Diageo
DEO
$49B
$288K 0.09%
1,500
– –
BIL icon
118
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$279K 0.09%
3,050
– –
MDC
119
DELISTED
M.D.C. Holdings, Inc.
MDC
$262K 0.08%
5,184
– –
CNP icon
120
CenterPoint Energy
CNP
$27.7B
$260K 0.08%
10,600
– –
AMZN icon
121
Amazon
AMZN
$2.92T
$258K 0.08%
1,500
– –
OGN icon
122
Organon & Co
OGN
$3.56B
$251K 0.08%
+8,299
New +$273K
VTRS icon
123
Viatris
VTRS
$20.4B
$250K 0.08%
17,519
-303
-2% -$4.38K
DLX icon
124
Deluxe
DLX
$1.18B
$239K 0.08%
5,000
– –
PM icon
125
Philip Morris
PM
$297B
$218K 0.07%
+2,200
New +$211K
2 3 4
5
6

Similar funds

GCP
Gill Capital Partners Denver, Colorado $348M AUM 14.74% 1-Year Est. Return
AWA
Argos Wealth Advisors Sacramento, California $348M AUM
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return
LAM
LOM Asset Management Hamilton $348M AUM 29.69% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $346M AUM 25.49% 1-Year Est. Return
VW
Vance Wealth Santa Clarita, California $346M AUM 19.74% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

Argyle Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Argyle Capital Management held 133 positions worth $309M, up 4.3% from $297M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Argyle Capital Management's Q2 2021 filing shows 3 new, 7 increased, 18 reduced and 4 closed positions. Its largest new stake was Organon & Co: 8,299 shares worth $251K. The largest sale was Perspecta Inc. Common Stock, an estimated $522K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Argyle Capital Management's largest Q2 2021 buy was Organon & Co: 8,299 shares worth $251K.
  • Argyle Capital Management added most to Fiserv Inc in Q2 2021, an estimated $93K increase.
  • Argyle Capital Management's biggest Q2 2021 reduction was Merck, cutting an estimated $303K.
  • Argyle Capital Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $522K.
  • Argyle Capital Management's ten largest holdings make up 23% of its $309M portfolio in Q2 2021.
  • Argyle Capital Management opened 3 new positions and closed 4 in Q2 2021.
  • Argyle Capital Management's portfolio value rose 4.3% quarter-over-quarter to $309M.

Based on Argyle Capital Management's 13F filing for Q2 2021, filed 27 Jul 2021.